{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:37:11Z","timestamp":1787024231206,"version":"build-2736575974"},"reference-count":92,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,15]]},"DOI":"10.2146\/ajhp140630","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T12:12:38Z","timestamp":1441627958000},"page":"1544-1554","source":"Crossref","is-referenced-by-count":79,"title":["Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings"],"prefix":"10.1093","volume":"72","author":[{"given":"Megan","family":"Corrigan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Advocate Illinois Masonic Medical Center, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprat Saely","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Detroit Receiving Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hampton","sequence":"additional","affiliation":[{"name":"Truman Medical Center, Kansas City, MO, and Clinical Assistant Professor,School of Pharmacy, University of Missouri\u00c2\u0097Kansas City, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041008432419100_b1-0721544","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0736-4679(88)90243-0","article-title":"Epidemiology of needlestick injury in emergency medical service personnel","volume":"6","author":"Hochreiter","year":"1988","journal-title":"J Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b2-0721544","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/bmj.38706.742731.47","article-title":"Intramuscular gluteal injections in the increasingly obese population: retrospective study","volume":"332","author":"Nisbet","year":"2006","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041008432419100_b3-0721544","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ajem.2013.09.001","article-title":"Predictors of epinephrine autoinjector needle length inadequacy","volume":"31","author":"Bhalla","year":"2013","journal-title":"Am J Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b4-0721544","first-page":"1","article-title":"Anatomy and physiology of the nose","volume-title":"Nasal systemic drug delivery","author":"Chien","year":"1989"},{"key":"key\n\t\t\t\t2019041008432419100_b5-0721544","first-page":"261","article-title":"Mechanism of nasal absorption of drugs","volume":"292","author":"Hussain","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"key\n\t\t\t\t2019041008432419100_b6-0721544","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1034\/j.1399-6576.2002.460702.x","article-title":"Nasal administration of opioids for pain management in adults","volume":"46","author":"Dale","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"key\n\t\t\t\t2019041008432419100_b7-0721544","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jps.2600760709","article-title":"Analysis of structure requirements for the absorption of drugs and macromolecules from the nasal cavity","volume":"76","author":"McMartin","year":"1987","journal-title":"J Pharm Sci"},{"key":"key\n\t\t\t\t2019041008432419100_b8-0721544","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:PHAR.0000026823.82950.ff","article-title":"Nasal route and drug delivery systems","volume":"26","author":"Turker","year":"2004","journal-title":"Pharm World Sci"},{"key":"key\n\t\t\t\t2019041008432419100_b9-0721544","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.eujps.2010.06.001","article-title":"Intranasal administration of opioids\/fentanyl\u2014physiological and pharmacological aspects","volume":"43","author":"Dale","year":"2010","journal-title":"Eur J Pain Suppl"},{"key":"key\n\t\t\t\t2019041008432419100_b10-0721544","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10611869808997870","article-title":"Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?","volume":"5","author":"Mathison","year":"1998","journal-title":"J Drug Target"},{"key":"key\n\t\t\t\t2019041008432419100_b11-0721544","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.2042-7158.1991.tb03510.x","article-title":"Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity","volume":"436","author":"Sakane","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"key\n\t\t\t\t2019041008432419100_b12-0721544","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.103.063222","article-title":"Brain uptake of the glucagon-like peptide-1 antagonist exendin after intranasal administration","volume":"309","author":"Banks","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041008432419100_b13-0721544","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pharmtox.43.100901.140251","article-title":"Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts","volume":"43","author":"Ding","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key\n\t\t\t\t2019041008432419100_b14-0721544","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/713714452","article-title":"Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier","volume":"10","author":"Minn","year":"2002","journal-title":"J Drug Target"},{"key":"key\n\t\t\t\t2019041008432419100_b15-0721544","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1023\/A:1015952320372","article-title":"Drug absorption through mucosal membranes: effect of mucosal route and penetrant hydrophilicity","volume":"6","author":"Corbo","year":"1989","journal-title":"Pharm Res"},{"key":"key\n\t\t\t\t2019041008432419100_b16-0721544","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/jps.2600741210","article-title":"Mechanism of nasal absorption of drugs II: absorption of L-tyrosine and the effect of structural modification on its absorption","volume":"74","author":"Huang","year":"1985","journal-title":"J Pharm Sci"},{"key":"key\n\t\t\t\t2019041008432419100_b17-0721544","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2005.09.047","article-title":"Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant","volume":"110","author":"Matsuyama","year":"2006","journal-title":"J Control Release"},{"key":"key\n\t\t\t\t2019041008432419100_b18-0721544","first-page":"458","article-title":"Studies on octanol-water partition coefficient and nasal drug absorption","volume":"32","author":"Jiang","year":"1997","journal-title":"Yao Xue Xue Bao"},{"key":"key\n\t\t\t\t2019041008432419100_b19-0721544","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.2174\/138920112803341752","article-title":"Drug delivery systems from nose to brain","volume":"13","author":"Misra","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"key\n\t\t\t\t2019041008432419100_b20-0721544","unstructured":"Teleflex. LMA MAD Nasal: needle-free intranasal drug delivery. www.lmana.com\/pwpcontrol.php?pwpID=6359 (accessed 2014 Nov 25)."},{"key":"key\n\t\t\t\t2019041008432419100_b21-0721544","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/bja\/aen072","article-title":"Plasma concentrations and sedation scores after nebulized and intranasal midazolam in healthy volunteers","volume":"100","author":"McCormick","year":"2008","journal-title":"Br J Anaesth"},{"key":"key\n\t\t\t\t2019041008432419100_b22-0721544","first-page":"22","article-title":"Latest advances in drug-delivery technology","volume":"10","author":"Bommer","year":"1999","journal-title":"Med Device Technol"},{"key":"key\n\t\t\t\t2019041008432419100_b23-0721544","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00405-006-0071-5","article-title":"Influence of anatomy and head position on intranasal drug deposition","volume":"263","author":"Merkus","year":"2006","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"key\n\t\t\t\t2019041008432419100_b24-0721544","unstructured":"BD. Accuspray nasal spray system. www.bd.com\/pharmaceuticals\/products\/nasal-spray.asp (accessed 2014 Nov 25)."},{"key":"key\n\t\t\t\t2019041008432419100_b25-0721544","unstructured":"Go Medical. Nasal PCA. www.gomedical.com.au\/products\/nasalspray.php (accessed 2014 Nov 25)."},{"key":"key\n\t\t\t\t2019041008432419100_b26-0721544","unstructured":"Kurvetech. ViaNase data sheet. www.kurvetech.com\/pdf\/ViaNaseDataSheet.pdf (accessed 2014 Apr 8)."},{"key":"key\n\t\t\t\t2019041008432419100_b27-0721544","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.2042-7158.1985.tb05069.x","article-title":"Intranasal drug delivery by spray and drops","volume":"37","author":"Hardy","year":"1985","journal-title":"J Pharm Pharmacol"},{"key":"key\n\t\t\t\t2019041008432419100_b28-0721544","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2125.2001.01325.x","article-title":"Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations","volume":"51","author":"Daley-Yates","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041008432419100_b29-0721544","first-page":"321","article-title":"A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration","volume":"20","author":"Henry","year":"1998","journal-title":"Pediatr Dent"},{"key":"key\n\t\t\t\t2019041008432419100_b30-0721544","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02527870","article-title":"Pharmacokinetics of intranasal fentanyl","volume":"7","author":"Striebel","year":"1993","journal-title":"Schmerz"},{"key":"key\n\t\t\t\t2019041008432419100_b31-0721544","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/11531740-000000000-00000","article-title":"Formulations of fentanyl for the management of pain","volume":"70","author":"Grape","year":"2010","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2019041008432419100_b32-0721544","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2044.2003.03286.x","article-title":"A new formulation of nasal fentanyl spray for postoperative analgesia: a pilot study","volume":"58","author":"Paech","year":"2003","journal-title":"Anaesthesia"},{"key":"key\n\t\t\t\t2019041008432419100_b33-0721544","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1442-2026.1999.00020.x","article-title":"A prospective randomized pilot comparison of intranasal fentanyl and intramuscular morphine for analgesia in children presenting to the emergency department with clinical fractures","volume":"11","author":"Younge","year":"1999","journal-title":"Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b34-0721544","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.annemergmed.2006.06.016","article-title":"A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department","volume":"49","author":"Borland","year":"2007","journal-title":"Ann Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b35-0721544","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1553-2712.2010.00905.x","article-title":"Use of intranasal fentanyl for the relief of pediatric orthopedic trauma pain","volume":"17","author":"Saunders","year":"2010","journal-title":"Acad Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b36-0721544","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1742-6723.2009.01216.x","article-title":"Intranasal fentanyl in 1-3-year-olds: a prospective study of the effectiveness of intranasal fentanyl as acute analgesia","volume":"21","author":"Cole","year":"2009","journal-title":"Emerg Med Australas"},{"key":"key\n\t\t\t\t2019041008432419100_b37-0721544","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/emj.2008.070474","article-title":"Intranasal fentanyl for analgesia in the paediatric emergency department","volume":"27","author":"Finn","year":"2010","journal-title":"Emerg Med J"},{"key":"key\n\t\t\t\t2019041008432419100_b38-0721544","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1442-2026.2002.00344.x","article-title":"Intranasal fentanyl reduces acute pain in children in the emergency department: a safety and efficacy study","volume":"14","author":"Borland","year":"2002","journal-title":"Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b39-0721544","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1742-6723.2011.01391.x","article-title":"Equivalency of two concentrations of fentanyl administered by the intranasal route for acute analgesia in children in a paediatric emergency department: a randomized controlled trial","volume":"23","author":"Borland","year":"2011","journal-title":"Emerg Med Australas"},{"key":"key\n\t\t\t\t2019041008432419100_b40-0721544","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1742-6723.2010.01257.x","article-title":"Does the standard intravenous solution of fentanyl (50 mcg\/mL) administered intranasally have analgesic efficacy?","volume":"22","author":"Crellin","year":"2010","journal-title":"Emerg Med Australas"},{"key":"key\n\t\t\t\t2019041008432419100_b41-0721544","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1553-2712.2009.00636.x","article-title":"The implementation of intranasal fentanyl for children in a mixed adult and pediatric emergency department reduces time to analgesic administration","volume":"17","author":"Holdgate","year":"2010","journal-title":"Acad Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b42-0721544","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.annemergmed.2013.10.025","article-title":"Safety of intranasal fentanyl in the out-of-hospital setting: a prospective observational study","volume":"63","author":"Karlsen","year":"2014","journal-title":"Ann Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b43-0721544","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ajem.2007.02.027","article-title":"A randomized controlled trial of intranasal fentanyl vs intravenous morphine for analgesia in the prehospital setting","volume":"25","author":"Rickard","year":"2007","journal-title":"Am J Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b44-0721544","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/10903127.2010.497896","article-title":"Effectiveness of morphine, fentanyl, and methoxyflurane in the prehospital setting","volume":"14","author":"Middleton","year":"2010","journal-title":"Prehosp Emerg Care"},{"key":"key\n\t\t\t\t2019041008432419100_b45-0721544","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF03005373","article-title":"Comparison of intravenous and intranasal sufentanil absorption and sedation","volume":"36","author":"Helmers","year":"1989","journal-title":"Can J Anaesth"},{"key":"key\n\t\t\t\t2019041008432419100_b46-0721544","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ajem.2012.02.019","article-title":"Intranasal sufentanil for the treatment of acute pain in a winter resort clinic","volume":"30","author":"Steenblik","year":"2012","journal-title":"Am J Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b47-0721544","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5055\/jom.2012.0121","article-title":"Intranasal sufentanil provides adequate analgesia for emergency department patients with extremity injuries","volume":"8","author":"Stephen","year":"2012","journal-title":"J Opioid Manag"},{"key":"key\n\t\t\t\t2019041008432419100_b48-0721544","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/j.2055-2335.2008.tb00836.x","article-title":"Pharmacokinetics and bioavailability of hydromorphone nasal spray","volume":"38","author":"Lim","year":"2008","journal-title":"J Pharm Pract Res"},{"key":"key\n\t\t\t\t2019041008432419100_b49-0721544","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1213\/01.ANE.0000066311.40978.4F","article-title":"Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers","volume":"97","author":"Coda","year":"2003","journal-title":"Anesth Analg"},{"key":"key\n\t\t\t\t2019041008432419100_b50-0721544","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpain.2009.05.002","article-title":"A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury","volume":"11","author":"Wermeling","year":"2010","journal-title":"J Pain"},{"key":"key\n\t\t\t\t2019041008432419100_b51-0721544","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.annemergmed.2010.11.030","article-title":"Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update","volume":"57","author":"Green","year":"2011","journal-title":"Ann Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b52-0721544","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00000542-198312000-00016","article-title":"Comparison of continuous infusion fentanyl or ketamine versus thiopental\u2014determining the mean effective serum concentrations for outpatient surgery","volume":"59","author":"White","year":"1983","journal-title":"Anesthesiology"},{"key":"key\n\t\t\t\t2019041008432419100_b53-0721544","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/bja\/77.2.203","article-title":"Ketamine and norketamine plasma concentrations after IV, nasal and rectal administration in children","volume":"77","author":"Malinovsky","year":"1996","journal-title":"Br J Anaesth"},{"key":"key\n\t\t\t\t2019041008432419100_b54-0721544","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/acem.12229","article-title":"Intranasal ketamine for analgesia in the emergency department: a prospective observational series","volume":"20","author":"Andolfatto","year":"2013","journal-title":"Acad Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b55-0721544","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1757-7241-21-38","article-title":"Prehospital analgesia using nasal administration of S-ketamine\u2014a case series","volume":"21","author":"Johansson","year":"2013","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b56-0721544","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1742-6723.12173","article-title":"Sub-dissociative-dose intranasal ketamine for moderate to severe pain in adult emergency department patients","volume":"26","author":"Yeaman","year":"2014","journal-title":"Emerg Med Australas"},{"key":"key\n\t\t\t\t2019041008432419100_b57-0721544","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.53.3.537","article-title":"The prevalence and characteristics of migraine in a population-based cohort: the GEM study","volume":"53","author":"Launer","year":"1999","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2019041008432419100_b58-0721544","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/jn.1944.7.6.359","article-title":"Spreading depression of activity in cerebral cortex","volume":"7","author":"Leao","year":"1944","journal-title":"J Neurophysiol"},{"key":"key\n\t\t\t\t2019041008432419100_b59-0721544","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0006-8993(95)00692-J","article-title":"Tolerance to ketamine-induced blockade of cortical spreading depression transfers to MK-801 but not to AP5 in rats","volume":"693","author":"Rashidy-Pour","year":"1995","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t2019041008432419100_b60-0721544","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","article-title":"A randomized controlled trial of intranasal ketamine in migraine with prolonged aura","volume":"80","author":"Afridi","year":"2013","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2019041008432419100_b61-0721544","doi-asserted-by":"crossref","first-page":"82","DOI":"10.55460\/7DN3-A0JX","article-title":"The tactical combat casualty card (TCCCC) guidelines\u2014proposed change 1301","volume":"13","author":"Kotwal","year":"2013","journal-title":"J Spec Oper Med"},{"key":"key\n\t\t\t\t2019041008432419100_b62-0721544","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10903120802290778","article-title":"Pain management in current combat operations","volume":"13","author":"Black","year":"2009","journal-title":"Prehosp Emerg Care"},{"key":"key\n\t\t\t\t2019041008432419100_b63-0721544","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pain.2003.07.001","article-title":"Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study","volume":"108","author":"Carr","year":"2004","journal-title":"Pain"},{"key":"key\n\t\t\t\t2019041008432419100_b64-0721544","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejpain.2009.08.002","article-title":"Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain","volume":"14","author":"Huge","year":"2010","journal-title":"Eur J Pain"},{"key":"key\n\t\t\t\t2019041008432419100_b65-0721544","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nurt.2009.01.002","article-title":"Intranasal delivery of antiepileptic medications for treatment of seizures","volume":"6","author":"Wermeling","year":"2009","journal-title":"Neurotherapeutics"},{"key":"key\n\t\t\t\t2019041008432419100_b66-0721544","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2125.2002.01588.x","article-title":"Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers","volume":"53","author":"Knowester","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041008432419100_b67-0721544","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1053\/seiz.2000.0425","article-title":"Is intranasal midazolam an effective rescue medication in adolescents and adults with severe epilepsy?","volume":"9","author":"Scheepers","year":"2000","journal-title":"Seizure"},{"key":"key\n\t\t\t\t2019041008432419100_b68-0721544","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/088307380201700206","article-title":"Efects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study","volume":"17","author":"Fisgin","year":"2002","journal-title":"J Child Neurol"},{"key":"key\n\t\t\t\t2019041008432419100_b69-0721544","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/PEC.0b013e3180328c92","article-title":"Prehospital intranasal midazolam for the treatment of pediatric seizures","volume":"23","author":"Holsti","year":"2007","journal-title":"Pediatr Emerg Care"},{"key":"key\n\t\t\t\t2019041008432419100_b70-0721544","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2005.09.006","article-title":"Intranasal midazolam vs rectal diazepam in acute childhood seizures","volume":"34","author":"Bhattacharyya","year":"2006","journal-title":"Pediatr Neurol"},{"key":"key\n\t\t\t\t2019041008432419100_b71-0721544","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1528-1167.2009.02333.x","article-title":"A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations","volume":"51","author":"De Haan","year":"2010","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t2019041008432419100_b72-0721544","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.321.7253.83","article-title":"Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study","volume":"321","author":"Lahat","year":"2000","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041008432419100_b73-0721544","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.yebeh.2004.01.003","article-title":"Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children","volume":"5","author":"Mahmoudian","year":"2004","journal-title":"Epilepsy Behav"},{"key":"key\n\t\t\t\t2019041008432419100_b74-0721544","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","article-title":"Clinical pharmacokinetics of atypical antipsychotics","volume":"46","author":"Mauri","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t2019041008432419100_b75-0721544","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1592\/phco.28.7.875","article-title":"Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study","volume":"28","author":"Miller","year":"2008","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041008432419100_b76-0721544","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1176\/ajp.149.4.500","article-title":"Haloperidol plasma levels and clinical response: a therapeutic window relationship","volume":"149","author":"Van Putten","year":"1992","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019041008432419100_b77-0721544","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/10903120903144866","article-title":"Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose","volume":"13","author":"Robertson","year":"2009","journal-title":"Prehosp Emerg Care"},{"key":"key\n\t\t\t\t2019041008432419100_b78-0721544","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/10903120290938797","article-title":"Intranasal administration of naloxone by paramedics","volume":"6","author":"Barton","year":"2002","journal-title":"Prehosp Emerg Care"},{"key":"key\n\t\t\t\t2019041008432419100_b79-0721544","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jemermed.2005.03.007","article-title":"Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting","volume":"29","author":"Barton","year":"2005","journal-title":"J Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b80-0721544","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5694\/j.1326-5377.2005.tb06550.x","article-title":"Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose","volume":"182","author":"Kelly","year":"2005","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t2019041008432419100_b81-0721544","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF03018846","article-title":"Plasma concentrations of flumazenil following intranasal administration in children","volume":"47","author":"Scheepers","year":"2000","journal-title":"Can J Anesth"},{"key":"key\n\t\t\t\t2019041008432419100_b82-0721544","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1460-9592.2009.03069_1.x","article-title":"Intranasal flumazenil and naloxone to reverse over-sedation in a child undergoing dental restorations","volume":"19","author":"Heard","year":"2009","journal-title":"Pediatr Anesth"},{"key":"key\n\t\t\t\t2019041008432419100_b83-0721544","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jemermed.2012.01.059","article-title":"A poison center\u2019s ten-year experience with flumazenil administration to acutely poisoned adults","volume":"43","author":"Kreshak","year":"2012","journal-title":"J Emerg Med"},{"key":"key\n\t\t\t\t2019041008432419100_b84-0721544","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/00003246-199212000-00022","article-title":"Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose","volume":"20","author":"Mordel","year":"1992","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t2019041008432419100_b85-0721544","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0168-8227(92)90042-P","article-title":"Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients","volume":"17","author":"Rosenfalck","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"key\n\t\t\t\t2019041008432419100_b86-0721544","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0168-3659(93)90179-9","article-title":"Absorption enhancers in nasal drug delivery: efficacy and safety","volume":"24","author":"Merkus","year":"1993","journal-title":"J Control Release"},{"key":"key\n\t\t\t\t2019041008432419100_b87-0721544","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/bmj.287.6390.462-a","article-title":"Intranasal glucagon raises blood glucose concentrations in healthy volunteers","volume":"287","author":"Pontiroli","year":"1983","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t2019041008432419100_b88-0721544","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/BF02374475","article-title":"Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus","volume":"36","author":"Stenninger","year":"1993","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041008432419100_b89-0721544","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00400568","article-title":"A new non-invasive method for treating insulin-reaction: intranasal lypophylized glucagon","volume":"33","author":"Slama","year":"1990","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041008432419100_b90-0721544","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/diacare.12.9.604","article-title":"Intranasal glucagon as a remedy for hypoglycemia","volume":"12","author":"Pontiroli","year":"1989","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041008432419100_b91-0721544","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00195909","article-title":"Glucose recovery after intranasal glucagon during hypoglycaemia in man","volume":"46","author":"Hvidberg","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041008432419100_b92-0721544","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/10903127.2012.717171","article-title":"Successful administration of intranasal glucagon in the out-of-hospital environment","volume":"17","author":"Sibley","year":"2013","journal-title":"Prehosp Emerg Care"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/18\/1544\/28318685\/ajhp1544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T20:05:12Z","timestamp":1718049912000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/18\/1544\/5111731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,15]]},"references-count":92,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,9,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140630","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,9,15]]},"published":{"date-parts":[[2015,9,15]]}}}